skip to main content

Methotrexate monitoring — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateMusculoskeletal TherapeuticsMethotrexate monitoringGPhC CRA

A patient on methotrexate asks why the GP checks bloods before issuing repeats. They feel well. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: AFull blood count, liver function and renal function according to schedule

Methotrexate can cause bone marrow suppression, hepatotoxicity and renal-related toxicity. The best answer addresses the key safety, legal or pharmaceutical care issue in the vignette. The other options would either delay appropriate care, create a new risk, or fail to resolve the issue. This is consistent with the cited UK reference for safe pharmacy practice.

Reference: BNF; NICE CKS